BIBCL latest shareholding pattern: promoter holding, FII / FPI holding, DII and mutual fund holding, public holding and number of shareholders, quarter by quarter.
As of Mar 2024, promoters held 59.25% of Bharat Immunologicals & Biologicals Corporation Ltd, FIIs -, DIIs -, government - and the public 40.74%, across 35,313 shareholders.